{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:04:23Z","timestamp":1785456263025,"version":"3.56.0"},"reference-count":36,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2002,4,5]],"date-time":"2002-04-05T00:00:00Z","timestamp":1017964800000},"content-version":"vor","delay-in-days":551,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2000,10]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic eosinophilic rhinosinusitis underlies a range of respiratory disorders including nasal polyposis. Surgical and medical methods are used to control polyps, with topical steroids commonly being used for their anti\u2010inflammatory properties. Fluticasone propionate nasal drops (FPND) is a formulation developed specifically for an effective and well tolerated corticosteroid treatment of nasal polyposis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To assess efficacy and tolerability of FPND in the treatment of bilateral nasal polyposis in adults.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This multicentre, randomized, parallel\u2010group study compared FPND 400\u2003\u03bcg once daily (o.d.) with placebo for 12\u2003weeks in adult patients with mild to moderate bilateral polyposis. The primary efficacy endpoint was visual assessment of polyp size by the physician at monthly clinic visits. Nasal blockage, rhinitis, peak nasal inspiratory flow (PNIF), olfactory function and requirement for polypectomy were also assessed at visits. The patients kept diary card records of symptoms, PNIF, and use of rescue antihistamine. Additional safety data were provided by a 12\u2010week open extension, when all patients received FPND 400\u2003\u03bcg o.d.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After 12\u2003weeks double\u2010blind treatment with FPND (<jats:italic>n<\/jats:italic>\u2003=\u200352) or placebo (<jats:italic>n<\/jats:italic>\u2003=\u200352), polyp size was reduced in 27% and 16% of patients, respectively; clinical reduction of nasal blockage significantly favoured FPND over placebo (55% vs 22%; <jats:italic>P\u2003<\/jats:italic>=\u20030.002), and clinic PNIF had increased significantly with FPND (by 52\u2003L\/min vs \u22123\u2003L\/min for placebo; <jats:italic>P\u2003<\/jats:italic>&lt;\u20030.001). Diary card measurements showed significant benefits of FPND vs placebo for daily PNIF, nasal blockage, rhinitis and use of loratadine rescue medication. Both treatments were well tolerated and no serious adverse events occurred during randomized treatment. Epistaxis was more frequent with FPND than placebo but was generally mild and did not result in withdrawals. Mean serum cortisol levels did not change significantly with either treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study showed FPND 400\u2003\u03bcg o.d. to be an effective and well tolerated treatment for bilateral nasal polyposis in adults.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2222.2000.00932.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T09:41:05Z","timestamp":1047375665000},"page":"1460-1468","source":"Crossref","is-referenced-by-count":84,"title":["Efficacy and tolerability of fluticasone propionate nasal drops 400\u2003\u03bcg once daily compared with placebo for the treatment of bilateral polyposis in adults"],"prefix":"10.1111","volume":"30","author":[{"given":"P.","family":"Keith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hollingworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dolovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,4,5]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"Drake\u2010LeeAB. Nasal Polyps. In: MacKay I. ed. Rhinitis: Mechanisms and Management London: Royal Society of Medicine Services Ltd. 1989:141\u201352."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00455133"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000233182"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-59989570012-9"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00020840-199802000-00007"},{"key":"e_1_2_6_7_2","first-page":"183","article-title":"Staging in rhinosinusitis","volume":"31","author":"Lund VJ","year":"1993","journal-title":"Rhinology"},{"key":"e_1_2_6_8_2","first-page":"126","article-title":"Position statement on nasal polyps","volume":"32","author":"Lildholdt T","year":"1994","journal-title":"Rhinology"},{"key":"e_1_2_6_9_2","first-page":"221","article-title":"Budesonide in the treatment of nasal polyposis","volume":"63","author":"Holopainen E","year":"1982","journal-title":"Eur J Respir Dis"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1995.tb00007.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)63180-8"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.124.5.513"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199714010-00006"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80069-7"},{"key":"e_1_2_6_15_2","first-page":"332","article-title":"Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis","volume":"67","author":"Nathan RA","year":"1991","journal-title":"Ann Allergy"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1995.tb00011.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1985.tb05069.x"},{"issue":"43","key":"e_1_2_6_18_2","first-page":"158","article-title":"Systemic bioavailability of fluticasone propionate administered as nasal drops (FP\u2010Drops) and aqueous nasal spray formulations (FPANS)","volume":"53","author":"Daley\u2010Yates PT","year":"1998","journal-title":"Allergy"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.303.6805.761"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100120997"},{"issue":"43","key":"e_1_2_6_21_2","first-page":"109","article-title":"The efficacy and tolerability of fluticasone propionate (FP) nasal drops 400 \u03bcg once daily and twice daily compared with placebo in the treatment of nasal polyposis","volume":"53","author":"Penttil\u00e4 M","year":"1998","journal-title":"Allergy"},{"key":"e_1_2_6_22_2","unstructured":"MackayIS. Topical medical management of allergic conditions of the nose. Part 2: Intranasal steroids. In: MacKay I. ed. Rhinitis: Mechanisms and Management London: Royal Society of Medicine Services Ltd. 1989:183\u201398."},{"key":"e_1_2_6_23_2","first-page":"344","article-title":"The peak nasal inspiratory flow meter: a new instrument for the assessment of the response to immunotherapy in seasonal allergic rhinitis","volume":"8","author":"Youlten LJF","year":"1980","journal-title":"Allergol Immunopathol"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(84)90269-5"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/chemse\/14.4.479"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.1998.00096.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.2500\/108854196778662228"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1993.tb00628.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80158-7"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6498.788"},{"key":"e_1_2_6_31_2","first-page":"49","article-title":"Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy","volume":"23","author":"Dings\u00f8r G","year":"1985","journal-title":"Rhinology"},{"key":"e_1_2_6_32_2","first-page":"9","article-title":"The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy","volume":"18","author":"Virolainen E","year":"1980","journal-title":"Rhinology"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199753050-00014"},{"key":"e_1_2_6_34_2","unstructured":"KeithP DolovichJ. Allergy and nasal polyposis. In: Mygind NLindholdt T. eds. Nasal Polyposis \u2212 an Inflammatory Disease and its Treatment. Copenhagen: Munksgaard 1997:68\u201377."},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.2500\/108854196778662237"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1996.tb00652.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.50.3.270"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.2000.00932.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.2000.00932.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2222.2000.00932.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:41:18Z","timestamp":1698579678000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2222.2000.00932.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["10.1046\/j.1365-2222.2000.00932.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2222.2000.00932.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}